Status:
COMPLETED
Endothelial NO Synthase Polymorphic Gene in Coronary Artery Dilation Disease
Lead Sponsor:
Cairo University
Conditions:
Coronary Artery Ectasia
Eligibility:
All Genders
18+ years
Brief Summary
Introduction: The coronary artery dilatations disease (Coronary artery aneurysm/coronary artery ectasia) characterized by inappropriate coronary artery dilations. (c.894G\>T) is a gene polymorphism th...
Detailed Description
Aim of Work We aim at determining the potential correlations between polymorphism of nitric oxide gene (c.894G\>T) and angiographically dilated coronary arteries (coronary artery aneurysm or ectasia),...
Eligibility Criteria
Inclusion
- Patients who have angiographically coronary artery dilatations (coronary artery aneurysm or ectasia) (CAA/CAE) with or without angiographic evidence of atherosclerotic CAD.
- Another group of patients with angiographically normal or atherosclerotic coronaries without evidence of dilatation.
Exclusion
- Patients with secondary coronary dilatations after balloon angioplasty, coronary stent implantation, patients with coronary artery bypass surgery who have post CABG native coronary dilatations, all were excluded from this study.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06220682
Start Date
December 1 2020
End Date
June 30 2022
Last Update
January 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo university
Cairo, Egypt, 11345